Sudarshan Pharma Industries Limited (SPIL), a Mumbai-based company founded in 2008, has a contract manufacturing facility to find and provide generic formulations. Additionally, it supplies specialised chemicals, APIs (Active Pharmaceutical Ingredients), and intermediates in addition to engaging in import and export operations. They contract with suppliers in India and other countries to manufacture products based on the specifications and demands of their customers.

The company’s generic goods are widely used in the adhesive, food, paint, and pharmaceutical industries. Hospitals, non-profit organisations, the government, and healthcare institutions can purchase drugs and pharmaceutical formulations from the corporation, which also provides these services. There are 50 pharmaceutical formulations produced by SPIL that are sold under the brand name and are available as tablets, ointments, capsules, and injectables.

For the ethical marketing of pharmaceutical formulations and products under the brand name in Indian and foreign markets, the company has its own sales force and distribution network in five states. Additionally, it provides customised solutions and formulation development and quality control services.

The following are the company’s competitive advantages:
1. A corporate approach that prioritises customers and orders
2. A variety of product options
3. Arrangements for contract manufacturing facilities
4. Robust sales, marketing, and distribution networks
5. A variety of business ventures